Local Institution

Newark, Delaware 19718

0 studies enrolling now · 10 studies all time

What they study most

Bladder Cancer, Breast Neoplasms, Cancer, Carcinoma, Non-Small-Cell Lung, Coronary Artery Disease, Diabetes Mellitus, Heart Disease, Hypertension, Ischemic Heart Disease, Metastasis, Neoplasm Metastasis, Thrombosis

Studies at this site

• Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" — Completed
• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress. — Stopped early
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer — Stopped early
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma — Completed
• PPAR - Combination With Metformin — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer — Stopped early